Information about Avalo Therapeutics Europe
My details
*
*
*

Avalo Therapeutics Europe (SRL)

Company information

Status
Active

Enterprise number

BE0716.860.484

VAT liability
Yes
Established
26-12-2018
Last balance sheet year
2024
Company size
Micro 0 FTE
Principal activity
Manufacture of medicaments
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from Avalo Therapeutics Europe

2024 2023 2022 2021
Profit/Loss -8,489 -1 % -8,405 2 % -8,550 8 % -9,272
Equity 5,135 -62 % 13,625 -38 % 22,030 598 % -4,420
Gross margin -7,978 -1 % -7,901 6 % -8,440 8 % -9,185

Publications from Avalo Therapeutics Europe

Date Publication
28-08-2025 Miscellaneous (FR)
27-06-2024 Resignations - Appointments (NL)
17-11-2022 Resignations - Appointments (NL)
04-08-2022 Modification Legal Form - Designation - Resignations - Appointments (NL)
22-09-2021 Resignations - Appointments (NL)

Frequently asked questions

What is the VAT number of Avalo Therapeutics Europe?
The VAT number of Avalo Therapeutics Europe is BE 0716.860.484.
Wat is the PEPPOL ID of Avalo Therapeutics Europe?
There is no information available about the PEPPOL ID of Avalo Therapeutics Europe or the company is not yet registered on the PEPPOL network.
When was Avalo Therapeutics Europe founded?
Avalo Therapeutics Europe was founded on 26-12-2018.
What is the address of Avalo Therapeutics Europe?
The current registered office of Avalo Therapeutics Europe is located at Place des Barricades 13, 1000 Bruxelles.
When was the last time Avalo Therapeutics Europe filed their annual financial statements?
The most recent financial statements of Avalo Therapeutics Europe were filed on 08-07-2025.
How many employees does Avalo Therapeutics Europe have?
There are currently no employees working at Avalo Therapeutics Europe or no workforce information is available.
What is the annual turnover of Avalo Therapeutics Europe?
At the time of its most recent financial statements, Avalo Therapeutics Europe did not publish any turnover figures. Avalo Therapeutics Europe reported a gross margin of -€7,978.00.